Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas

<p>Abstract</p> <p>Background</p> <p>The X-linked <it>SRPX2 </it>gene encodes a Sushi Repeat-containing Protein of unknown function and is mutated in two disorders of the Rolandic/Sylvian speech areas. Since it is linked to defects in the functioning and the development of brain areas for speech production, <it>SRPX2 </it>may thus have participated in the adaptive organization of such brain regions. To address this issue, we have examined the recent molecular evolution of the <it>SRPX2 </it>gene.</p> <p>Results</p> <p>The complete coding region was sequenced in 24 human X chromosomes from worldwide populations and in six representative nonhuman primate species. One single, fixed amino acid change (R75K) has been specifically incorporated in human SRPX2 since the human-chimpanzee split. The R75K substitution occurred in the first sushi domain of SRPX2, only three amino acid residues away from a previously reported disease-causing mutation (Y72S). Three-dimensional structural modeling of the first sushi domain revealed that Y72 and K75 are both situated in the hypervariable loop that is usually implicated in protein-protein interactions. The side-chain of residue 75 is exposed, and is located within an unusual and SRPX-specific protruding extension to the hypervariable loop. The analysis of non-synonymous/synonymous substitution rate (Ka/Ks) ratio in primates was performed in order to test for positive selection during recent evolution. Using the branch models, the Ka/Ks ratio for the human branch was significantly different (p = 0.027) from that of the other branches. In contrast, the branch-site tests did not reach significance. Genetic analysis was also performed by sequencing 9,908 kilobases (kb) of intronic <it>SRPX2 </it>sequences. Despite low nucleotide diversity, neither the HKA (Hudson-Kreitman-Aguadé) test nor the Tajima's D test reached significance.</p> <p>Conclusion</p> <p>The R75K human-specific variation occurred in an important functional loop of the first sushi domain of SRPX2, indicating that this evolutionary mutation may have functional importance; however, positive selection for R75K could not be demonstrated. Nevertheless, our data contribute to the first understanding of molecular evolution of the human <it>SPRX2 </it>gene. Further experiments are now required in order to evaluate the possible consequences of R75K on SRPX2 interactions and functioning.</p

Functional Variant in Complement C3 Gene Promoter and Genetic Susceptibility to Temporal Lobe Epilepsy and Febrile Seizures

BACKGROUND: Human mesial temporal lobe epilepsies (MTLE) represent the most frequent form of partial epilepsies and are frequently preceded by febrile seizures (FS) in infancy and early childhood. Genetic associations of several complement genes including its central component C3 with disorders of the central nervous system, and the existence of C3 dysregulation in the epilepsies and in the MTLE particularly, make it the C3 gene a good candidate for human MTLE. METHODOLOGY/PRINCIPAL FINDINGS: A case-control association study of the C3 gene was performed in a first series of 122 patients with MTLE and 196 controls. Four haplotypes (HAP1 to 4) comprising GF100472, a newly discovered dinucleotide repeat polymorphism [(CA)8 to (CA)15] in the C3 promoter region showed significant association after Bonferroni correction, in the subgroup of MTLE patients having a personal history of FS (MTLE-FS+). Replication analysis in independent patients and controls confirmed that the rare HAP4 haplotype comprising the minimal length allele of GF100472 [(CA)8], protected against MTLE-FS+. A fifth haplotype (HAP5) with medium-size (CA)11 allele of GF100472 displayed four times higher frequency in controls than in the first cohort of MTLE-FS+ and showed a protective effect against FS through a high statistical significance in an independent population of 97 pure FS. Consistently, (CA)11 allele by its own protected against pure FS in a second group of 148 FS patients. Reporter gene assays showed that GF100472 significantly influenced C3 promoter activity (the higher the number of repeats, the lower the transcriptional activity). Taken together, the consistent genetic data and the functional analysis presented here indicate that a newly-identified and functional polymorphism in the promoter of the complement C3 gene might participate in the genetic susceptibility to human MTLE with a history of FS, and to pure FS. CONCLUSIONS/SIGNIFICANCE: The present study provides important data suggesting for the first time the involvement of the complement system in the genetic susceptibility to epileptic seizures and to epilepsy

Infantile Convulsions with Paroxysmal Dyskinesia (ICCA Syndrome) and Copy Number Variation at Human Chromosome 16p11

BACKGROUND: Benign infantile convulsions and paroxysmal dyskinesia are episodic cerebral disorders that can share common genetic bases. They can be co-inherited as one single autosomal dominant trait (ICCA syndrome); the disease ICCA gene maps at chromosome 16p12-q12. Despite intensive and conventional mutation screening, the ICCA gene remains unknown to date. The critical area displays highly complicated genomic architecture and is the site of deletions and duplications associated with various diseases. The possibility that the ICCA syndrome is related to the existence of large-scale genomic alterations was addressed in the present study. METHODOLOGY/PRINCIPAL FINDINGS: A combination of whole genome and dedicated oligonucleotide array comparative genomic hybridization coupled with quantitative polymerase chain reaction was used. Low copy number of a region corresponding to a genomic variant (Variation_7105) located at 16p11 nearby the centromere was detected with statistical significance at much higher frequency in patients from ICCA families than in ethnically matched controls. The genomic variant showed no apparent difference in size and copy number between patients and controls, making it very unlikely that the genomic alteration detected here is ICCA-specific. Furthermore, no other genomic alteration that would directly cause the ICCA syndrome in those nine families was detected in the ICCA critical area. CONCLUSIONS/SIGNIFICANCE: Our data excluded that inherited genomic deletion or duplication events directly cause the ICCA syndrome; rather, they help narrowing down the critical ICCA region dramatically and indicate that the disease ICCA genetic defect lies very close to or within Variation_7105 and hence should now be searched in the corresponding genomic area and its surrounding regions

Les épilepsies humaines associées à d'autres pathologies cérébrales (identification d'un gène responsable d'une épilepsie rolandique et d'un trouble du langage)

L'épilepsie est une des maladies neurologiques les plus fréquentes. Les troubles du langage, également très fréquents, touchent 2 à 7% des enfants entrant à l'école. Dans l'épilepsie rolandique, le langage mérite une attention particulière, les décharges épileptiques impliquant les aires périsylviennes du langage. Un gène responsable d'une dyspraxie orale et de la parole associée à une épilepsie rolandique a été localisé en Xq21-q22. La mutation causale a été identifiée dans le gène SRPX2, codant pour une protéine sécrétée à domaines sushi. Cette mutation crée un site de N-glycosylation. Dans des cellules en culture, la protéine mutante est N-glycosylée et, soit sécrétée, soit retenue dans le RE et ubiquitinylée. Dans le cerveau de l'homme adulte, SRPX2 est exprimée dans les neurones de l'aire rolandique. Dans le cerveau murin, l'expression de Srpx2 apparaît dans les neurones à la naissance. Ainsi, SRPX2 serait un facteur moléculaire essentiel du langage au niveau de l'aire rolandiqueEpilepsy is one of the most common neurological diseases (1-4%). Language impairments are very frequents, affecting 2-7% of children entering school. Language processing deserves particular attention in rolandic epilepsy as discharges involve the perisylvian language areas. A gene for oral and speech dyspraxia associated with rolandic epilepsy was mapped at Xq21-q22. Systematic screening identified the disease-causing mutation within the SRPX2 gene encoding a secreted sushi-repeat containing protein. The mutation created a N-glycosylation site. In cultured cells, mutant SRPX2 protein was N-glycosylated and either secreted, or retained in the endoplasmic reticulum as ubiquitin-linked derivatives. In the human adult brain, SRPX2 was expressed in neurons of the rolandic area. In the murine brain, Srpx2 protein expression appeared in neurons at birth. Altogether, our data identify SRPX2 as an important molecular agent of language processing in the rolandic areaAIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocPARIS-BIUP (751062107) / SudocSudocFranceF

Lipid inclusions accumulation in macrophages from peritoneal effusion of a newborn

International audienc

Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples

International audienc

Pleural effusion in a patient with Ewing sarcoma

International audienc